High-dose ICE With Amifostine
This study has been completed.
Dana-Farber Cancer Institute
First Posted: March 31, 2004
Last Update Posted: January 20, 2017
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Paul G. Richardson, MD, Dana-Farber Cancer Institute
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||June 2002|
|Primary Completion Date:||November 2000 (Final data collection date for primary outcome measure)|
Elias AD, Richardson P, Tretyakov O, et al.: Amifostine with high dose infosfamide, carboplatin, and etoposide (ICE) with hematopoietic STEM cell support. [Abstract] Proceedings of the American Society of Clinical Oncology 19: A197, 2000.